Quality assurance in neuropathology: experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019

Saved in:

Bibliographic Details
Main Authors:	Riemenschneider, Markus Johannes (Author) , Fischer, Josephine (Author) , Grassow-Narlik, Maja (Author) , Mawrin, Christian (Author) , Deimling, Andreas von (Author) , Pietsch, Torsten (Author) , Reifenberger, Guido (Author) , Müller, Wolf C. (Author) , Sommer, Clemens (Author) , Dietel, Manfred (Author) , Zoubaa, Saida (Author) , Lorenz, Julia (Author) , Rothhammer-Hampl, Tanja (Author)
Format:	Article (Journal)
Language:	English
Published:	[2020]
In:	Clinical neuropathology Year: 2020, Volume: 39, Issue: 5, Pages: 203-211
DOI:	10.5414/NP301278
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.5414/NP301278 Verlag, lizenzpflichtig, Volltext: https://www.dustri.com/article_response_page.html?artId=186681&doi=10.5414/NP301278&L=0
Author Notes:	Markus J. Riemenschneider, Josephine Fischer, Maja Grassow-Narlik, Christian Mawrin, Andreas von Deimling, Torsten Pietsch, Guido Reifenberger, Wolf C. Mueller, Clemens J. Sommer, Manfred Dietel, Saida Zoubaa, Julia Lorenz, Tanja Rothhammer-Hampl

Similar Items